Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease-Reference-Cited by-同舟云学术

Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease

Published:2013-02-09 Issue:3 Volume:88 Page:179-184
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Turkia Hadhami Ben¹,Gonzalez Derlis E.²,Barton Norman W.³,Zimran Ari⁴,Kabra Madhulika⁵,Lukina Elena A.⁶,Giraldo Pilar⁷,Kisinovsky Isaac⁸,Bavdekar Ashish⁹,Dridi Marie-Françoise Ben¹,Gupta Neerja⁵,Kishnani Priya S.¹⁰,Sureshkumar E.K.¹¹,Wang Nan³,Crombez Eric³,Bhirangi Kiran³,Mehta Atul¹²

Affiliation:

1. La Rabta Hospital; Tunis; Tunisia

2. Sanatorio Español; Asunción; Paraguay

3. Shire Human Genetic Therapies, Inc.; Lexington; Massachusetts

4. Shaare Zedek Medical Center and Hebrew University-Hadassah Medical School; Jerusalem; Israel

5. All India Institute of Medical Sciences; New Delhi; India

6. Hematology Research Center; Moscow; Russia

7. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) and Hospital Universitario Miguel Servet; Zaragoza; Spain

8. Your Health S. A.; Buenos Aires; Argentina

9. KEM Hospital Research Centre; Pune; India

10. Duke University Medical Center; Durham; North Carolina

11. Malabar Institute of Medical Sciences Ltd.; Calicut; India